Hero

Celyad Reports Full Year 2019 Financial Results and Provides Business Update

1

Celyad Reports Full Year 2019 Financial Results and Provides Business Update

Celyad Appoints Stephen Rubino as Chief Business Officer

2

Celyad Appoints Stephen Rubino as Chief Business Officer

Celyad Announces February and March 2020 Conference Schedule

3

Celyad Announces February and March 2020 Conference Schedule

Development of the Next Generation NKG2D CAR T-cell Manufacturing Process

4

Development of the Next Generation NKG2D CAR T-cell Manufacturing Process

About Celyad

Making the Impossible Possible

Celyad is a clinical-stage biopharmaceutical that is developing next generation CAR-T NK cell-based immunotherapies for cancer treatment.

Latest News

Celyad Reports Full Year 2019 Financial Results and Provides Business Update

Celyad Reports Full Year 2019 Financial Results and Provides Business Update

Celyad to Announce Full Year 2019 Financial Results and Host Conference Call

Celyad to Announce Full Year 2019 Financial Results and Host Conference Call

Celyad Appoints Stephen Rubino as Chief Business Officer

Celyad Appoints Stephen Rubino as Chief Business Officer

Discover all news

Carousel

Social Feed

Interview of Filippo Petti, CEO of Celyad, about "Bridging the Gap in Personalised Medicine with CAR T Cell Therapi… https://t.co/5hSUvj8iBL

1 day ago

Interview of Filippo Petti, CEO of Celyad, about "Bridging the Gap in Personalised Medicine with CAR T Cell Therapi… https://t.co/5hSUvj8iBL

In these corona times, our teams keep working hard from home or our lab to continue to develop therapies for cancer… https://t.co/CrIvOs0bNC

2 weeks ago

In these corona times, our teams keep working hard from home or our lab to continue to develop therapies for cancer… https://t.co/CrIvOs0bNC

Join our call later today. Dial-in info available on our website: https://t.co/kiGpVYJw9m $CYAD https://t.co/oKYtww6wWM

2 weeks ago

Join our call later today. Dial-in info available on our website: https://t.co/kiGpVYJw9m $CYAD https://t.co/oKYtww6wWM

Celyad Reports Full Year 2019 Financial Results and Provides Business Update https://t.co/IvgczqKPmI https://t.co/k30WYQJGku

2 weeks ago

Celyad Reports Full Year 2019 Financial Results and Provides Business Update https://t.co/IvgczqKPmI https://t.co/k30WYQJGku

Interview of Filippo Petti, CEO of Celyad, about "Bridging the Gap in Personalised Medicine with CAR T Cell Therapi… https://t.co/5hSUvj8iBL

1 day ago

Interview of Filippo Petti, CEO of Celyad, about "Bridging the Gap in Personalised Medicine with CAR T Cell Therapi… https://t.co/5hSUvj8iBL

In these corona times, our teams keep working hard from home or our lab to continue to develop therapies for cancer… https://t.co/CrIvOs0bNC

2 weeks ago

In these corona times, our teams keep working hard from home or our lab to continue to develop therapies for cancer… https://t.co/CrIvOs0bNC

Join our call later today. Dial-in info available on our website: https://t.co/kiGpVYJw9m $CYAD https://t.co/oKYtww6wWM

2 weeks ago

Join our call later today. Dial-in info available on our website: https://t.co/kiGpVYJw9m $CYAD https://t.co/oKYtww6wWM

Celyad Reports Full Year 2019 Financial Results and Provides Business Update https://t.co/IvgczqKPmI https://t.co/k30WYQJGku

2 weeks ago

Celyad Reports Full Year 2019 Financial Results and Provides Business Update https://t.co/IvgczqKPmI https://t.co/k30WYQJGku